Application
Application Process
Our program accepts applications only through ERAS (Electronic Residency Application Service) and participates in the NRMP Match. All interviews are conducted virtually.
The Internal Medicine Residency Program receives more than 6,000 applications annually for our 12 categorical positions. Selection is based on a variety of factors, including academic performance, letters of recommendation, personal qualities, clinical performance, and USMLE scores.
Due to the volume of applicants, we cannot guarantee email or phone responses to application or interview invitation inquiries. Applicants selected for an interview will receive instructions through ERAS, and interview scheduling will be completed through Thalamus.
Program Signals and Application Information
Our program reviews all components of the ERAS application. While applicants who signal our program may receive additional consideration during the interview selection process, program signals are not used when determining our rank list. We take a holistic approach to application review and consider a variety of factors, including academic performance, clinical experiences, letters of recommendation, personal qualities, and alignment with our program's mission and values.
Selection Criteria
· The ideal applicant will have single-attempt scores above 230 for USMLE Step 1 and 230 for USMLE Step 2 CK, or above 500 on each of COMLEX 1 and 2CE.
· Three letters of recommendation are required. It is preferred (but not required) that one letter be from a faculty member from your medical school or Department of Medicine Chair.
· Active clinical engagement is preferred.
· Research experience is helpful but not required.
· Graduation from medical school within five years is preferred, although consideration may be given to candidates who have completed advanced postgraduate training.
Visa Sponsorship
Guthrie may support J-1 visas, but reserves the right to withdraw or limit sponsorship if costs associated with sponsorship are, or become, prohibitive.